Cara Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: Vifor and CSL Reduce Stake in Tvardi Therapeutics Following Merger and Reverse Stock Splits
Vifor (International) Ltd. and CSL Limited have reported a reduction in their beneficial ownership of Tvardi Therapeutics, Inc. common stock to 2.2% following a series of reverse stock splits and a merger.